he ECNP Congress that occurs annually is Europe’s largest meeting on applied and translational neuroscience.
Held in autumn every year, the Congress brings together a vibrant group of psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of brain disorders. With around 6000 participants, the ECNP congress is Europe’s premier showcase for new research, treatments and technologies in applied brain science. Spanning the spectrum of human mood, behaviour, cognition and emotion, the congress covers most brain-related aspects from basic science to clinical care.
This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF’s funded investigators and leading scientists in the field present their current research progress and stimulate discussion. The conference offers ample opportunity for collaboration and partnering.Find out more »
As technology in rare disease accelerates, and with topics like drug pricing being a top priority in government, we must act now to drive innovation and collaboration to develop stronger resources, better outcomes and find cures for the community. In 2019, we believe The Time is Now to prioritize action in making positive changes for the millions of Americans living with rare diseases.Find out more »
The Ninth Annual Fall Symposium & Luncheon “Hope on the Horizon” comprised a morning symposium with leading Alzheimer’s researchers and a luncheon to present the Charles Evans Award.Find out more »
ISPOR Europe 2019 convenes an international, interdisciplinary audience of 5000+ healthcare stakeholders that include policy makers, payers, thought leaders, researchers, decision makers, and patient representatives.Find out more »
The development of the next generation of Alzheimer’s disease treatments is among the most important health needs worldwide, but presents huge challenges. The goal of the meeting is to bring together today’s worldwide leaders in the treatment of Alzheimer’s disease to discuss new results, candidate therapeutics, and methodological issues important to the development of the next generation of Alzheimer’s disease treatments.Find out more »
Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy and Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Resource Management, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence, Post-Marketing Studies, Observational Research, Accessing and Generating RWD, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, Clinical Biomarkers and Biospecimens, and Central Lab Solutions, and an all new track on Medical Device Clinical Trial Operations and Regulations.Find out more »
The ASENT 2020 Annual Meeting features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders. Technological breakthroughs featured include the use of DBS, spinal cord stimulation, genomic-based drug discovery, new drug delivery systems.Find out more »
The Meeting will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.Find out more »
For more than 50 years, DIA has provided the world’s largest global, neutral stage for life science professionals to come together and address healthcare challenges. Driven by purpose and focused on the future of health, the stakeholders who gather at the Global Annual Meeting advance science and technology for public health impact – today, and for generations to come.Find out more »
The Alzheimer’s Association International Conference® is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC® convenes the world’s leading basic science and clinical researchers, next-generation investigators, clinicians and the care research community to share research discoveries that’ll lead to methods of prevention and treatment and improvements in the diagnosis of Alzheimer’s disease.
We are delighted to be participating in this year’s, first ever virtual AAIC conference.
If you’re interested in discussing current or upcoming studies or learning how your AD cognitive assessments can be adapted in this remote landscape, we invite you to ping us, and we’ll schedule time for a video call.
Our team of science and operational experts, including Paul Maruff, Chris Edgar, Ed Bartolic, and Karin Wallace are all blocking time for meetings during the conference and are here to help you advance your study.
Find out more »
The International Symposium of MPS 2020 in Barcelona is an event organized and coordinated by MPS Spain in collaboration with different MPS societies worldwide.
It is a space for dissemination and exchange of knowledge between the medical-scientific community and affected families, in order to bring the latest developments in research, treatment, clinical management and comprehensive care of mucopolysaccharidoses and related syndromes.
It is a meeting point that brings together the best international experts, as well as different medical societies, scientists and the pharmaceutical industry related to these pathologies.